Skip to main content

Published locations for Malignancy Rates Remain Stable in Ustekinumab-Treated Patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Malignancy Rates Remain Stable in Ustekinumab-Treated Patients

User login

  • Reset your password
  • /content/malignancy-rates-remain-stable-ustekinumab-treated-patients
  • /edermatologynews/article/47222/melanoma/malignancy-rates-remain-stable-ustekinumab-treated-patients
  • /oncologypractice/article/47222/melanoma/malignancy-rates-remain-stable-ustekinumab-treated-patients
  • /hematology-oncology/article/47222/melanoma/malignancy-rates-remain-stable-ustekinumab-treated
  • /dermatology/article/47222/melanoma/malignancy-rates-remain-stable-ustekinumab-treated-patients
  • /dermatology/psoriasiscollection/article/47222/melanoma/malignancy-rates-remain-stable-ustekinumab